Rabicip-D Rabeprazole Sodium and Domperidone Capsules are intended to be used for treatment of excessive gastric acid production and symptomatic gastroesophageal reflux disease. They belong to drug class of proton pump inhibitors and assure excellent effectiveness. These capsules get quickly absorbed through parietal cells of stomach and exert their curative action. They are known to work by binding to H+/K+ ATPase pump which results in blocking of final step of gastric acid production. Rabicip-D Rabeprazole Sodium and Domperidone Capsules are metabolized in liver with help of CYP2C19 and CYP3A4 with excellent protein binding ability of 96.3%.